GobyMeds vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

GobyMeds beats MEDVi overall, scoring 8.4/10 vs 7.7/10. GobyMeds is more affordable at $169/mo vs $299/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed comp. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side comparison of GobyMeds and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

GobyMeds

#5 of 48

8.4/10

Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.

Visit GobyMeds

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	GobyMeds	MEDVi
Our Score	8.4/10	7.7/10
Starting Price	$169/mo	$299/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program	Users who want a low entry price with oral and injectable compounded options
Ranking	#5	#22

Pros & Cons Compared

GobyMeds

Pros

+$119/mo starting price is among the most affordable for a full-service compounded program
+Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
+Modern patient portal with real-time order tracking and easy provider messaging
+Quick onboarding — most patients approved and shipped within 48 hours of enrollment

Cons

−Compounded semaglutide only — no tirzepatide, no brand-name, no oral options
−Newer company with less track record than established players like Ro or Hims
−No insurance billing and no superbills for FSA/HSA reimbursement

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

GobyMeds edges out MEDVi with a score of 8.4/10 vs 7.7/10. If budget is your priority, GobyMeds starts at $169/mo compared to MEDVi's $299/mo. Choose GobyMeds if you want: budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither GobyMeds nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review